Stock Events

Stock Events

Summit Therapeutics (SMMT) Q2 2026 Earnings

30AprConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.76

-0.54

-0.31

-0.09

Details

Expected EPS

-0.269222

Actual EPS

-0.24

Surprise EPS

0.03

Surprise Percent

+10.85%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.24 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.